AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HEALIUS LTD

0.670

-0.015-2.19%

Volume:3.83M

Turnover:2.59M

Market Cap:486.51M

PE:-2.91

High:0.690

Open:0.680

Low:0.665

Close:0.685

52wk High:1.197

52wk Low:0.662

Shares:726.13M

Float Shares:648.47M

Volume Ratio:0.51

T/O Rate:0.59%

Dividend:0.41

Dividend Rate:61.64%

EPS(TTM):-0.230

EPS(LYR):-0.208

ROE:-69.35%

ROA:0.45%

PB:0.87

PE(LYR):-3.22

Loading ...

Overview Company News Filings

BUZZ-Australia's Healius drops on bigger-than-expected half-year loss

Healius Posts Narrower Fiscal H1 Underlying Loss, Higher Revenue

MT Newswires Live

Healius H1 Revenue Continuing Operations AUD 688.1 Million

THOMSON REUTERS

Australian Healthcare Stocks Look Primed for M&A -- Market Talk

CEO Transitions Create Risks for Australian Healthcare Investors -- Market Talk

Healius Limited (ASX:HLS) Looks Inexpensive But Perhaps Not Attractive Enough

Simply Wall St.

Healius Ltd-Board Changes

THOMSON REUTERS

BRIEF-Healius Wins Contract For Supply Of Services To ADF

Healius Signs Contract With Australian Department of Defence

MT Newswires Live

Healius Ltd - Contract Starts Dec 2025 for Initial Five-Year Period

THOMSON REUTERS

Healius Ltd - Signs Contract With Australian Defence for Pathology Services

THOMSON REUTERS

Healius Ltd - Total Revenue Expected to Be a$60 Mln for Contract Period

THOMSON REUTERS

We’re not in Kansas anymore

BUZZ-Australia's October Medicare growth muted; Jefferies holds view on healthcare providers

Healius Reaffirms Fiscal Year 2026 Revenue Growth Guidance

MT Newswires Live

Healius Ltd-Appointment of Company Secretary

THOMSON REUTERS

BRIEF-Healius Ltd Announces Appointment Of Andrew Thomson As CFO

Healius Appoints New CFO

MT Newswires Live

Healius Ltd - Appointment of Andrew Thomson as New Chief Financial Officer

THOMSON REUTERS

Healius Needs Longer in Recovery Room -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HLS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HLS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HLS.AU\",,,,,undefined,":{"symbol":"HLS.AU","market":"AU","secType":"STK","nameCN":"HEALIUS LTD","latestPrice":0.67,"timestamp":1771909920000,"preClose":0.685,"halted":0,"volume":3827771,"delay":0,"changeRate":-0.02189781021897812,"nameEN":"HEALIUS LTD","floatShares":648466707,"shares":726132843,"eps":-0.23045,"marketStatus":"Not Yet Opened","change":-0.015,"latestTime":"02-24 16:12:00 AEDT","open":0.68,"high":0.69,"low":0.665,"amount":2588402,"amplitude":0.036496,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.23045,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771974000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.685,"dividendRate":0.616418,"openAndCloseTimeList":[[1771887600000,1771909200000]],"volumeRatio":0.5127835422004635,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"HLS.AU\",,,,,undefined,":{"symbol":"HLS.AU","floatShares":648466707,"roa":"0.45%","roe":"-69.35%","lyrEps":-0.208227,"volumeRatio":0.5127835422004635,"shares":726132843,"dividePrice":0.413,"high":0.69,"amplitude":0.036496,"preClose":0.685,"low":0.665,"week52Low":0.662,"pbRate":"0.87","psRate":"0.36","week52High":1.197,"institutionHeld":0,"latestPrice":0.67,"eps":-0.23045,"divideRate":0.616418,"volume":3827771,"delay":0,"ttmEps":-0.23045,"open":0.68,"prevYearClose":0.905,"prevWeekClose":0.69,"prevMonthClose":0.9,"prevQuarterClose":0.905,"fiveDayClose":0.815,"twentyDayClose":0.935,"sixtyDayClose":1,"dividendPayoutRate":0.3174518941928099,"dividendGrowthYears":1,"dividendGrowthRate":5.883333333333333,"fiveYearAvgDividendRate":0.13286655691160723},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-18","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771369200000,"name":null,"time":"","dateTimestamp":1771333200000,"actualEps":null},{"date":"2025-08-21","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-05-09","symbol":"HLS.AU","amount":0.413,"announcedDate":"2025-05-05","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-12","defaultRemindTime":1746748800000,"name":"HEALIUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-23","payableDate":"2025-05-12","currency":"AUD","dateTimestamp":1746712800000,"payDate":"2025-05-23"},{"date":"2025-02-20","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null},{"date":"2024-08-21","symbol":"HLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724198400000,"name":null,"time":"","dateTimestamp":1724162400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLS.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-15","value":0.065,"currency":"AUD"},{"executeDate":"2021-09-13","recordDate":"2021-09-14","paymentDate":"2021-10-08","value":0.0675,"currency":"AUD"},{"executeDate":"2022-03-24","recordDate":"2022-03-25","paymentDate":"2022-04-05","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-07","recordDate":"2022-09-08","paymentDate":"2022-09-21","value":0.06,"currency":"AUD"},{"executeDate":"2025-05-09","recordDate":"2025-05-12","paymentDate":"2025-05-23","value":0.413,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HLS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612490465","title":"BUZZ-Australia's Healius drops on bigger-than-expected half-year loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2612490465","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612490465?lang=en_us&edition=fundamental","pubTime":"2026-02-18 12:18","pubTimestamp":1771388330,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Healius drops on bigger-than-expected half-year loss** Shares of Australia's Healius HLS.AX fall 11.4% to A$0.723, their lowest since late August** Healthcare co posts half-year underlying loss after tax of A$11 million ,** HY loss is smaller than the loss recorded a year earlier, but misses the VA consensus estimate of A$2.2 mln ** Jarden notes that although cost reductions have offset corporate costs at face value, it appears to have been swapped out with a step up in one-off termination costs of A$20.8 mln. ** This is well above the brokerage's expectations after co indicated earlier that there would be no further restructuring costs** However, Jarden notes Agilex segment performed better, helped by closure of loss-making toxicology business** Jefferies notes pathology revenue and EBITDA margins increased in HY ** YTD, shares down 13.2% ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL6N3ZE06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7509","HLS.AU","BK7124"],"gpt_icon":0},{"id":"2612049968","title":"Healius Posts Narrower Fiscal H1 Underlying Loss, Higher Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2612049968","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612049968?lang=en_us&edition=fundamental","pubTime":"2026-02-18 07:29","pubTimestamp":1771370983,"startTime":"0","endTime":"0","summary":"Healius  reported on Wednesday a fiscal first-half underlying loss of AU$0.015 per share, compared with a AU$0.028 loss per share a year earlier.Analysts polled by FactSet expected a loss of AU$0.01.Revenue from continuing operations for the six months ended Dec. 31, 2025, was AU$688.1 million, compared with AU$662.3 million a year earlier. Analysts surveyed by FactSet expected AU$687 million.The company expects fiscal 2026 earnings to align with current consensus estimates and anticipates achieving high single-digit earnings before interest and taxes margins by June 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7124","BK7509","HLS.AU"],"gpt_icon":0},{"id":"2612460073","title":"Healius H1 Revenue Continuing Operations AUD 688.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460073?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:18","pubTimestamp":1771363126,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nPLX86871B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7509","HLS.AU","BK7124"],"gpt_icon":0},{"id":"2604097010","title":"Australian Healthcare Stocks Look Primed for M&A -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604097010","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604097010?lang=en_us&edition=fundamental","pubTime":"2026-01-19 07:49","pubTimestamp":1768780140,"startTime":"0","endTime":"0","summary":"2349 GMT - M&A is a theme to watch among Australian healthcare stocks this year, RBC Capital Markets says. It points to low debt levels in the sector. Most companies covered by RBC are likely to have a leverage ratio of 1.5x or lower, analyst Craig Wong-Pan says. \"We believe the mix of new CEOs, low debt levels and challenging conditions could lead to potential M&A in 2026,\" RBC says. ResMed is likely to keep making small bolt-on acquisitions in respiratory care and adjacent markets, while Ansell could target small or medium-sized deals, RBC says. \"CSL has said it will pivot its R&D activities to focus more on development and it could undertake licensing or partnerships for later stage assets,\" it adds.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","HLS.AU","BK7509","RHC.AU","BK4588","BK4137","SHL.AU","HCSG","BK7501","BK7124","XBI","ANN.AU","BK7007","IDX.AU","BK4585","BK4581","COH.AU","LABU","BK7067","BK7508","LU0029874061.USD","BK7113","XLV","CSL.AU","MVF.AU","BK7126","LU0128526141.USD"],"gpt_icon":0},{"id":"2604709039","title":"CEO Transitions Create Risks for Australian Healthcare Investors -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604709039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604709039?lang=en_us&edition=fundamental","pubTime":"2026-01-19 07:41","pubTimestamp":1768779660,"startTime":"0","endTime":"0","summary":"2341 GMT - RBC Capital Markets's message to investors in Australian healthcare stocks: Be alert to CEO transition risks. Among companies that have changed leaders in recent months are Ansell, Sonic Healthcare, Integral Diagnostics and Monash IVF. \"The appointments of new CEOs follow long tenure periods under the previous management, and therefore we see possibilities for a combination of strategy resets, asset impairments, and 'kitchen sinking' guidance,\" says analyst Craig Wong-Pan. There could be operational disruptions from the management changes. Also, some managers who missed out on the CEO position could leave, RBC says. \"We also note there have been a number of new CFOs, including at CSL, Ramsay Health Care and Healius,\" it adds. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","LU0128526141.USD","BK7007","BK7113","BK4585","BK7511","BK7124","COH.AU","BK4137","IDX.AU","BK7501","LU0029874061.USD","LABU","BK7509","BK4211","MVF.AU","HLS.AU","RHC.AU","BK4588","HCSG","ISBC","BK7126","BK4581","CSL.AU","XBI","ANN.AU","BK7508","XLV","SHL.AU"],"gpt_icon":0},{"id":"2603635529","title":"Healius Limited (ASX:HLS) Looks Inexpensive But Perhaps Not Attractive Enough","url":"https://stock-news.laohu8.com/highlight/detail?id=2603635529","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603635529?lang=en_us&edition=fundamental","pubTime":"2026-01-13 04:13","pubTimestamp":1768248831,"startTime":"0","endTime":"0","summary":"When you see that almost half of the companies in the Healthcare industry in Australia have price-to-sales ratios (or...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-limited-asxhls-looks-inexpensive-but-perhaps-not-att","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-hls/healius-shares/news/healius-limited-asxhls-looks-inexpensive-but-perhaps-not-att","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HLS.AU","BK7501","BK7509","BK7124"],"gpt_icon":0},{"id":"2589806745","title":"Healius Ltd-Board Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2589806745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589806745?lang=en_us&edition=fundamental","pubTime":"2025-12-08 06:09","pubTimestamp":1765145384,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nTUE8ND4TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7509","HLS.AU","BK7124"],"gpt_icon":0},{"id":"2588747255","title":"BRIEF-Healius Wins Contract For Supply Of Services To ADF","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747255","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588747255?lang=en_us&edition=fundamental","pubTime":"2025-12-01 16:22","pubTimestamp":1764577377,"startTime":"0","endTime":"0","summary":"BRIEF-Healius Wins Contract For Supply Of Services To ADFDec 1  - Healius Ltd HLS.AX:SIGNS CONTRACT WITH AUSTRALIAN DEFENCE FOR PATHOLOGY SERVICESCONTRACT STARTS DEC 2025 FOR INITIAL FIVE-YEAR PERIODTOTAL REVENUE EXPECTED TO BE A$60 MILLION FOR CONTRACT PERIODFurther company coverage: HLS.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X600G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7509","HLS.AU","BK7124"],"gpt_icon":0},{"id":"2588674688","title":"Healius Signs Contract With Australian Department of Defence","url":"https://stock-news.laohu8.com/highlight/detail?id=2588674688","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588674688?lang=en_us&edition=fundamental","pubTime":"2025-12-01 13:41","pubTimestamp":1764567707,"startTime":"0","endTime":"0","summary":"Healius  said it has signed a contract with the Australian Department of Defence to provide private pathology services to the Australian Defence Force , according to a Monday Australian bourse filing.Total revenue over the initial period of the contract is expected to be approximately AU$60 million, the filing added.Under the contract, Healius, through its national pathology network, will provide a full range of outpatient pathology services to ADF personnel.The contract commences on Dec. 1 for an initial five-year period, with extensions for up to a further five years at the option of the Australian Defence Force.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7509","XKO.AU","XJO.AU","HLS.AU","BK7124","XAO.AU","BK7501"],"gpt_icon":0},{"id":"2588717542","title":"Healius Ltd - Contract Starts Dec 2025 for Initial Five-Year Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2588717542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588717542?lang=en_us&edition=fundamental","pubTime":"2025-12-01 10:32","pubTimestamp":1764556341,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X600G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLS.AU","BK7509","BK7501","BK7124"],"gpt_icon":0},{"id":"2588547717","title":"Healius Ltd - Signs Contract With Australian Defence for Pathology Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2588547717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588547717?lang=en_us&edition=fundamental","pubTime":"2025-12-01 10:32","pubTimestamp":1764556341,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X600G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7509","BK7501","HLS.AU"],"gpt_icon":0},{"id":"2588071754","title":"Healius Ltd - Total Revenue Expected to Be a$60 Mln for Contract Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2588071754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588071754?lang=en_us&edition=fundamental","pubTime":"2025-12-01 10:32","pubTimestamp":1764556341,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X600G:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7509","BK7501","HLS.AU"],"gpt_icon":0},{"id":"2586262069","title":"We’re not in Kansas anymore","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262069","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586262069?lang=en_us&edition=fundamental","pubTime":"2025-11-27 04:15","pubTimestamp":1764188107,"startTime":"0","endTime":"0","summary":"One only needs to glance at a map of the US equity market to determine ‘We’re not in Kansas anymore’. The era of network economics and ever greater financialisation has wrought massive change on equity markets and increasingly on the real economy.Ever-growing government deficits and strong ongoing growth in household borrowing are funding a relatively buoyant profit environment, albeit one that is distributed increasingly unevenly. Disequilibrium is becoming the norm and the economic forces which tended to work against this are proving ineffective. While the reasons for this ongoing disequilibrium are debatable, a few seem important.Keen to display the power of monetary intervention in ‘smoothing’ economic cycles and preventing any downturn, central bankers everywhere have ensured additional credit and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["HLS.AU","MQG.AU","BK7067","XKO.AU","BK7124","CSL.AU","BK7509","XJO.AU","BK7046","BK7511","XAO.AU","ACL.AU","SHL.AU","BK7508","MPL.AU","CBA.AU","BK7113","BK7089","BK7135","BK7501","RHC.AU"],"gpt_icon":0},{"id":"2586478262","title":"BUZZ-Australia's October Medicare growth muted; Jefferies holds view on healthcare providers","url":"https://stock-news.laohu8.com/highlight/detail?id=2586478262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586478262?lang=en_us&edition=fundamental","pubTime":"2025-11-27 03:26","pubTimestamp":1764185216,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's October Medicare growth muted; Jefferies holds view on healthcare providers** Jefferies says Australia's October Medicare data shows muted growth across pathology and imaging, with ge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nL6N3X212J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7124","SHL.AU","MVF.AU","BK7508","HLS.AU","BK7509","IDX.AU","BK7113"],"gpt_icon":0},{"id":"2579162117","title":"Healius Reaffirms Fiscal Year 2026 Revenue Growth Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2579162117","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579162117?lang=en_us&edition=fundamental","pubTime":"2025-10-30 13:58","pubTimestamp":1761803883,"startTime":"0","endTime":"0","summary":"Healius (ASX:HLS) reaffirmed that it expects revenue growth in fiscal year 2026 to be consistent with growth in the second half of fiscal year 2025, according to a Thursday filing with the Australian bourse.Shares of the company rose 5% at market close.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","BK7509","XJO.AU","HLS.AU","XAO.AU","XKO.AU","BK7501"],"gpt_icon":0},{"id":"2579944215","title":"Healius Ltd-Appointment of Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2579944215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579944215?lang=en_us&edition=fundamental","pubTime":"2025-10-29 12:38","pubTimestamp":1761712717,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUE4L2G0C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7501","HLS.AU","BK7124"],"gpt_icon":0},{"id":"2573189209","title":"BRIEF-Healius Ltd Announces Appointment Of Andrew Thomson As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2573189209","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573189209?lang=en_us&edition=fundamental","pubTime":"2025-10-08 09:31","pubTimestamp":1759887085,"startTime":"0","endTime":"0","summary":"BRIEF-Healius Ltd Announces Appointment Of Andrew Thomson As CFOOct 8  - Healius Ltd HLS.AX:APPOINTMENT OF ANDREW THOMSON AS NEW CHIEF FINANCIAL OFFICERAPPOINTMENT OF ANDREW THOMSON AS CFO FOLLOWING RETIREMENT OF STEVE HUMPHRIESFurther company coverage: HLS.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VO1Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","BK7501","HLS.AU","BK7124"],"gpt_icon":0},{"id":"2573699907","title":"Healius Appoints New CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2573699907","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573699907?lang=en_us&edition=fundamental","pubTime":"2025-10-08 06:08","pubTimestamp":1759874934,"startTime":"0","endTime":"0","summary":"Healius (ASX:HLS) appointed Andrew Thomson as new chief financial officer, effective Oct. 13, according to a Wednesday filing with the Australian bourse.Thomson will succeed current CFO Steve Humphries, following his retirement, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","HLS.AU","BK7509","XAO.AU","XKO.AU","XJO.AU","BK7124"],"gpt_icon":0},{"id":"2573760996","title":"Healius Ltd - Appointment of Andrew Thomson as New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2573760996","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573760996?lang=en_us&edition=fundamental","pubTime":"2025-10-08 05:23","pubTimestamp":1759872217,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO1Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","HLS.AU","BK7501","BK7124"],"gpt_icon":0},{"id":"2562229309","title":"Healius Needs Longer in Recovery Room -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2562229309","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562229309?lang=en_us&edition=fundamental","pubTime":"2025-08-25 09:01","pubTimestamp":1756083660,"startTime":"0","endTime":"0","summary":"0101 GMT - Pathology services provider Healius is showing signs of life after a rough patch, but Morgans isn't ready to turn bullish on its stock. Healius reported steady progress on its strategy to lift operating margins into the high-single-digit percentage range by end-FY 2027 through raising revenue and reducing costs. But analyst Derek Jellinek concludes that \"sustainable earnings growth is still questionable, execution risk is high, and there are plenty of uncertainties, including fair work commission proposals and recent Medicare changes to vitamin B12 and urine testing.\" Morgans retains a hold call on Healius's stock, and cuts its price target by 9.4% to A$0.87/share. Healius is unchanged at A$0.83. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLS.AU","BK7501","BK7509","BK7124"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}